Holen Sie sich die Stockscreener-App
15.67
1.82%
0.28
Vorhandelsmarkt:
15.74
0.07
+0.45%
Schlusskurs vom Vortag:
$15.39
Offen:
$15.45
24-Stunden-Volumen:
4.24M
Relative Volume:
0.52
Marktkapitalisierung:
$10.60B
Einnahmen:
$6.55B
Nettoeinkommen (Verlust:
$-551.40M
KGV:
-19.39
EPS:
-0.8082
Netto-Cashflow:
$438.90M
1W Leistung:
-0.89%
1M Leistung:
+5.81%
6M Leistung:
+98.35%
1J Leistung:
+16.94%
1-Tages-Spanne:
$0.00
$0.00
1-Wochen-Bereich:
$14.96
$16.38
52-Wochen-Spanne:
$7.265
$16.38
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, RMD, MDLN, ALC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
15.67 | 10.60B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
423.96 | 149.78B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
183.75 | 50.05B | 21.37B | 1.41B | 3.07B | 3.9437 |
RMD
Resmed Inc
|
230.05 | 32.35B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
36.26 | 31.81B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
64.11 | 30.99B | 10.63B | 819.00M | 1.59B | 1.6577 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-09 | Eingeleitet | UBS | Neutral |
| 2026-07-29 | Hochstufung | Jefferies | Underperform → Hold |
| 2026-06-26 | Fortgesetzt | Bernstein | Mkt Perform |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Underperform |
| 2026-05-15 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2026-03-06 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Barclays raises target for Avantor stock from USD 13.00 to USD 15.00 - AD HOC NEWS
Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock? - Zacks Investment Research
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Avantor Inc stock hits 52-week high at 16.05 USD - Investing.com
Avantor Inc stock hits 52-week high at 16.05 USD By Investing.com - Investing.com Nigeria
VTRS vs. AVTR: Which Stock Is the Better Value Option? - Zacks Investment Research
Avantor Inc stock hits 52-week high at 16.05 USD By Investing.com - Investing.com Canada
Avantor Inc (AVTR) Shares Surge 3.1% -- What GF Score of 71 Tells Investors - GuruFocus
Wall Street Zen downgrades Avantor to Hold. Avantor stock gains 1.98 percent - AD HOC NEWS
Global Methyl Grignard Reagent MarketStrategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth Opportunities - GlobeNewswire Inc.
Avantor Stock Price Forecast. Should You Buy AVTR? - StockInvest.us
Q2 Earnings Review: Research Tools & Consumables Stocks Led by Avantor (NYSE:AVTR) - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
AVANTOR® TO REPORT THIRD QUARTER 2026 EARNINGS ON WEDNESDAY, OCTOBER 28, 2026 - Moomoo
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - Morningstar
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - tradingview.com
Avantor® to Report Third Quarter 2026 Earnings on Wednesday, October 28, 2026 - Yahoo Finance
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Avantor (NYSE:AVTR)Stock Analysis - Simply Wall Street
Avantor Taps Todd Garner as CFO After Three-Month Interim - MyChesCo
Avantor, Inc. (AVTR) Stock forecasts - Yahoo Finance UK
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo! Finance Canada
Top Avantor (AVTR) Competitors 2026 - MarketBeat
A Look at Avantor Inc (AVTR) After 4.2% Gain -- GF Value $16.87 vs Price $15.38 - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Shareholders to Connect - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Forecasts - Yahoo Finance
At $16.61 a share, Avantor (AVTR) grants its CFO options that begin vesting in 2027. - Stock Titan
[Form 3] Avantor, Inc. Initial Statement of Beneficial Ownership - Stock Titan
How Avantor’s New CFO Appointment At Avantor (AVTR) Has Changed Its Investment Story - Yahoo Finance
Are Medical Stocks Lagging Avantor (AVTR) This Year? - Yahoo Finance
Avantor (AVTR) hires new CFO with seven-figure stock grants - Stock Titan
AVTR 8-K FilingsAvantor, Inc. SEC 8-K - Stock Titan
Avantor Names Todd Garner as CFO - Yahoo Finance
Avantor appoints new Chief Financial Officer - PR Newswire
Avantor Broadens RIM Single-Use Bioprocessing Reach in APAC - Yahoo Finance
Here's Why You Should Add Avantor Stock to Your Portfolio for Now - Yahoo Finance
Avantor Stock Has Strong Technical Momentum, But Make Sure Your Stop Losses Are Tight - Yahoo Finance
ETFs Investing in Avantor, Inc. Stocks - tradingview.com
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
(AVTR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Stock Analysis: Navigating the Healthcare Landscape with a Forward P/E of 16.98 - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out - ACCESS Newswire
2026-09-06 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Avantor, Inc. (AVTR) And Encourages Investors to Reach Out | NYSE:AVTR | Press Release - Stockhouse
Is Avantor (AVTR) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Avantor stock gains as investors focus on recent earnings and valuation - AD HOC NEWS
Avantor Q2 Earnings Beat Estimates on VWR Growth, Guidance Raised - Eastern Progress
Is It Too Late to Buy Avantor Inc (AVTR) After 3.2% Rally? GF Va - GuruFocus
Bronstein, Gewirtz & Grossman, LLC Is Investigating Avantor, Inc. (AVTR) And Encourages Stockholders to Connect - ACCESS Newswire
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Avantor Inc-Aktie (AVTR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Dingemans Simon | Director |
May 01 '26 |
Buy |
8.14 |
25,000 |
203,500 |
25,000 |
| MEHRA SANJEEV K | Director |
Mar 10 '26 |
Buy |
8.01 |
125,000 |
1,001,250 |
475,000 |
| LUCIER GREGORY T | Director |
Feb 19 '26 |
Buy |
9.16 |
50,000 |
458,000 |
50,000 |
| SUMME GREGORY L | Director |
Feb 12 '26 |
Buy |
9.40 |
100,000 |
940,000 |
400,000 |
| MEHRA SANJEEV K | Director |
Dec 05 '25 |
Buy |
11.09 |
350,000 |
3,881,500 |
350,000 |
| Ligner Emmanuel | President and CEO |
Nov 17 '25 |
Buy |
11.35 |
87,500 |
993,125 |
283,424 |
| Todd Edwards | officer |
Nov 06 '25 |
Proposed Sale |
25.16 |
29,131 |
732,926 |
0 |
| SUMME GREGORY L | Director |
Oct 30 '25 |
Buy |
11.25 |
100,000 |
1,125,000 |
300,000 |
0.13%
1.17%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):